| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 04/11/2001 | EP1090996A1 Vector expressing the full-length gene of rna virus and use thereof |
| 04/11/2001 | EP1090985A1 Feline-derived T-cells |
| 04/11/2001 | EP1090108A1 Novel methods for rescue of rna viruses |
| 04/11/2001 | EP1090033A1 Particles of hcv envelope proteins: use for vaccination |
| 04/11/2001 | EP0779929B1 Non self-inactivating, expression targeted retroviral vectors |
| 04/10/2001 | US6214982 Ribonuclease resistant RNA preparation and utilization |
| 04/10/2001 | US6214534 Deactivator of free radical associations; for the prevention of transfusion-associated graft-versus-host disease |
| 04/10/2001 | US6214354 Immunizing a person older than fifty who has had varicella or who has had a live varicella vaccine with immunologically effective amount of attenuated varicella zoster virus oka strain, where amount is at least 1,000 plaque forming units |
| 04/10/2001 | US6214353 Malaria recombinant poxvirus vaccine |
| 04/10/2001 | US6214333 Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
| 04/10/2001 | US6214221 Method and apparatus for purification of biological substances |
| 04/05/2001 | WO2001023597A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | WO2001023577A2 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences |
| 04/05/2001 | WO2001023414A2 Immunologically significant herpes simplex virus antigens |
| 04/05/2001 | WO2001023001A2 Rapid peg-modification |
| 04/05/2001 | WO2001022992A2 Influenza vaccine |
| 04/05/2001 | WO2000060087A3 Cyclin dependent kinase inhibitor genes from plants |
| 04/05/2001 | WO2000053789A3 Retroviral expression vectors on the basis of herv- long terminal repeat sequences |
| 04/05/2001 | WO2000030668A9 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 04/05/2001 | CA2616210A1 Influenza vaccine compositions |
| 04/05/2001 | CA2386014A1 Influenza vaccine |
| 04/05/2001 | CA2384814A1 Methods for rapid peg-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor |
| 04/05/2001 | CA2384382A1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | CA2379623A1 Immunologically significant herpes simplex virus antigens |
| 04/04/2001 | EP1088892A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 04/04/2001 | EP1088889A1 Recombinant double hybrid filamentous bacteriophage |
| 04/04/2001 | EP1088830A2 Hepatitis b surface antigen particles |
| 04/04/2001 | EP1088576A1 Liquid withdrawing tray for purification column, purification column and method for purification |
| 04/04/2001 | EP1088092A1 Replication-defective recombinant adenovirus with mutated major late promoter |
| 04/04/2001 | EP1088077A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 04/04/2001 | EP1087941A2 Thiolesters and uses thereof |
| 04/04/2001 | CN1290303A Use of negative regulation elements for nerve-specific expression of transgenes |
| 04/04/2001 | CN1289843A Hypotonic strain for virus of young parakeet |
| 04/04/2001 | CN1289626A Purification method and tower, and liquid seperating tower tray therefor |
| 04/03/2001 | US6211163 Injection; sustained release of expressed protein |
| 04/03/2001 | US6210946 Modified adenovirus containing a fiber replacement protein |
| 04/03/2001 | US6210682 Immunization against rotavirus infection or rotavirus disease by administering to a subject a peptide nsp4 114-135, a peptide nsp4 120-147, or a toxoid thereof are disclosed. |
| 03/29/2001 | WO2001021817A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 03/29/2001 | WO2001021807A1 Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof |
| 03/29/2001 | WO2001021216A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/29/2001 | WO2000037487A8 αvβ6 INTEGRIN INHIBITORS |
| 03/29/2001 | WO2000012741A9 Inducible expression system |
| 03/29/2001 | DE19962508A1 Verfahren zur Identifizierung von MHC-Restringierten Antigenen A method for identifying of MHC-restricted antigens |
| 03/29/2001 | CA2385664A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 03/29/2001 | CA2384827A1 Capsid-modified recombinant adenovirus and methods of use |
| 03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086207A1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 03/28/2001 | EP1085904A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 03/27/2001 | US6207455 Lentiviral vectors |
| 03/27/2001 | US6207439 Prepared by microfiltration, ultrafiltration, and then gel filtration of infected cell culture; vaccines |
| 03/27/2001 | US6207426 Preparing preferentially propagating microorganism plasmid; obtain plasmid, insert preferential nucleotide sequences, evaluate propagation in cells |
| 03/27/2001 | US6207416 Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 03/27/2001 | US6207415 Preparing polypeptides in poultry embryonic tissues; propagating poultry tissues until tissue begins senescence, concentrating tissues, isolate non-senescent cells and propagate, recover polypeptides from tissues |
| 03/27/2001 | US6207168 Vaccine composition for herpes simplex virus and methods of using |
| 03/27/2001 | US6207158 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 03/22/2001 | WO2001020014A1 Modified adenoviral vectors for use in gene therapy |
| 03/22/2001 | WO2001020013A2 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | WO2001019870A2 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | WO2001019380A2 Oncolytic virus |
| 03/22/2001 | WO2000074629A3 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 03/22/2001 | WO2000065038A3 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
| 03/22/2001 | CA2386530A1 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | CA2385308A1 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | CA2384860A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 03/22/2001 | CA2384439A1 Modified adenoviral vectors for use in gene therapy |
| 03/21/2001 | EP1084251A2 Attenuated pestiviruses |
| 03/21/2001 | EP1084236A1 Novel adenoviral vectors for gene therapy |
| 03/21/2001 | EP1083883A1 Stabilizers for lyophilized vaccines |
| 03/21/2001 | EP0797678B1 Hybrid adenovirus-aav virus and method of use thereof |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204251 Ocular gene therapy |
| 03/20/2001 | US6204060 Viral vectors and line for gene therapy |
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204044 Capsid protein; for the detection and prevention of viral infection |
| 03/20/2001 | US6203975 Adenovirus and method of use thereof |
| 03/15/2001 | WO2001018199A1 Chimaeric plant viruses with mucin peptides |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018058A2 Enhanced phage display library of human vh fragments and methods for producing same |
| 03/15/2001 | WO2001017553A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 03/15/2001 | CA2384388A1 Enhanced phage display library of human vh fragments and methods for producing same |
| 03/15/2001 | CA2383980A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 03/15/2001 | CA2349434A1 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 03/14/2001 | EP1083230A1 Viral replicons and viruses dependent on inducing agents |
| 03/14/2001 | EP1083229A1 Modified adenoviral vectors for use in gene therapy |
| 03/14/2001 | EP1083228A1 Modified adenoviral vectors for use in gene therapy |
| 03/14/2001 | EP1082446A1 Recombinant aav vectors for gene therapy of hemophilia a |
| 03/14/2001 | EP1082413A2 Aav5 vector and uses thereof |
| 03/14/2001 | EP1082340A1 Peptide vaccine for canine allergy |
| 03/14/2001 | CN1287573A Enhanced immunogen for inactivated vaccine for infection with Japanese ence phalitis Viruses and process for producing the same |
| 03/13/2001 | US6200811 For making human immunodeficiency virus resistant cells; gene therapy |
| 03/13/2001 | US6200800 Defective moloney murine leukemia provirus used as retroviral vector for gene therapy and vaccines; has recognition sequence for elimination of proviral sequences for more accurate and safe use |
| 03/13/2001 | US6200799 Replication-defective recombinant virus includes promoter from human major intrinsic protein or human crystallin and an open reading frame of human ras, herpes simplex type i thymidine kinase, or non-phosphorylatable retinoblastoma |
| 03/13/2001 | US6200798 Defective recombinant adenoviruses with inactivated IVa2 gene |
| 03/08/2001 | WO2001016344A1 Modified adenoviral fibre and uses thereof |
| 03/08/2001 | WO2001016331A1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 03/08/2001 | WO2001016330A2 Prevention of affections associated with porcine circovirus-2 |
| 03/08/2001 | WO2000026246A9 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |